Festina lente: Hydroxychloroquine, COVID-19 and the role of the rheumatologist
- Elizabeth R. Graef,
- Jean W. Liew,
- Michael S. Putman,
- Julia F. Simard,
- Emily Sirotich,
- Francis Berenbaum
- Beth Israel Deaconess Medical Center,
- University of Washington,
- Northwestern University Feinberg School of Medicine,
- Clinical Epidemiology Unit,
- Division of Immunology and Rheumatology Stanford School of Medicine,
- McMaster University
Research Output:
Contribution to journal
Review article
Peer-review
Open access
Publication Information
Output type
Research Output:
Contribution to journal
Review article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages S734-S736Journal (Volume, Issue Number)
Annals of the Rheumatic Diseases (Volume 79, Issue 6)Publication milestones
- Published - 01/06/2020
Publication status
Published - 01/06/2020
ISSN
0003-4967Publication IDs
- Scopus: 85083384822
- PubMed: 32295786
Funding Details
Competing interests FB reports personal fees from Boehringer, Bone Therapeutics, Expanscience, Galapagos, Gilead, GSK, Merck Sereno, MSD, Nordic, Novartis, Pfizer, Regulaxis, Roche, Sandoz, Sanofi, Servier, UCB, Peptinov, TRB Chemedica and 4P Pharma. RG reports personal fees from Pfizer, Cornerstones, Jannsen and Novartis. PK reports personal fees from GlaxoSmithKline, Sanofi-Aventis, Pfizer, Abbvie, Novartis Pharma, Eli Lilly and Bristol-Myers Squibb. AHJK reports grants from NIH (National Institutes of Health)/NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and Rheumatology Research Foundation and personal fees from Exagen Diagnostics and GlaxoSmithKline. JAS reports grants from NIH/NIAID (National Institute of Allergy and Infectious Diseases)/Autoimmune Centers of Excellence, the Rheumatology Research Foundation, the Brigham Research Institute and the R. Bruce and Joan M. Mickey Research Scholar Fund as well as personal fees from Bristol-Myers Squibb, Gilead, Inova, Janssen and Optum.
FundersFunding numbers
NIH
-NIAID
-NIAMS
T32AR048522
GSK
-Gilead Sciences
-RRF
-BRI
-Publication metrics
Metrics
PlumX, opens in new tab
Citations
40
Captures
220
Social media
1